(Press-News.org) Scientists at the Victor Chang Cardiac Research Institute in Australia have produced a first of its kind integrated map of heart cells which unlocks the process of cardiac fibrosis – a major cause of heart failure.
The discovery opens new avenues to develop targeted drugs to prevent scarring damage caused after a heart attack.
During and after a heart attack, the heart’s muscles are damaged leading to the formation of scar tissue which lacks the elasticity and contractility of healthy heart muscle. This damage is permanent and can affect the heart’s ability to pump blood, eventually leading to heart failure.
Professor Richard Harvey, who led the study alongside the Institute’s Dr Ralph Patrick and Dr Vaibhao Janbandhu, says the discovery is a major step forward in understanding cardiac fibrosis – which accompanies virtually all forms of heart disease including the overloading of the heart due to high blood pressure.
“Millions if not billions of dollars have been poured into seeking new drugs to control cardiac fibrosis over the years, but these efforts have largely failed. There is an urgent need to develop novel treatments that could arrest or even reverse cardiac fibrosis, benefiting millions,” says Professor Harvey.
“Fibrosis is an essential part of the body’s way of healing. But in the heart, if the disease triggers are not resolved, the process can go too far, causing scarring that is incredibly harmful to heart function and a major cause of heart failure.
“For the first time, using revolutionary technology that enables us to analyse gene expression in single cells, we have been able to map out the progressive cell states involved in cardiac fibrosis and how these cells evolve day by day."
The team analysed RNA signatures from 100,000 single cells focusing on those involved in fibrosis, integrating data from several pioneering studies on a variety of heart disease states.
It allowed them to produce an integrated cellular map of a mouse model heart that pinpoints cells and pathways involved in fibrosis.
The study identified resting cells, activated cells, an inflammatory population, a progenitor pool, dividing cells, and specialised cells called myofibroblasts and matrifibrocytes.
It discovered that myofibroblasts – which are believed to be the major drivers of scarring but absent in healthy hearts, start to form three days after a heart attack in a mouse model, before peaking at day five. They are then resolved to a form called matrifibrocytes, which may prevent the scar from resolving.
The study, published in Science Advances, also explored other heart disease models induced heart failure induced by high internal blood pressures as a result of aortic stenosis, or hypertension.
Dr Vaibhao Janbandhu says: “We found a surprising similarity in fibrosis progression in very different types of heart diseases. Myofibroblasts were abundant early on during hypertension and then resolved into matrifibrocytes, just as they are after a heart attack.
“This opens the doors to future therapies that will be able to target specific cell types or processes in different heart diseases. This will hopefully prevent healthy cells from being permanently damaged."
The study used data from both mouse models and human patients. In humans, heart failure may take decades to evolve, so the exact cell types and the timing of processes in human patients need to be explored in greater detail.
Dr Janbandhu adds: “Persistent high blood pressure can have devastating consequences, but it is treatable, highlighting the need to monitor for high blood pressure and get it under control quickly.”
The team has also created the ‘CardiacFibroAtlas’, a resource web tool for researchers worldwide. It allows users to visualize and analyse how genes behave in heart attacks and related health problems. Available at https://cardiacfibroatlas.victorchang.edu.au/
END
Mapping the heart to prevent damage caused by a heart attack
2024-06-21
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Study challenges popular idea that Easter islanders committed ‘ecocide’
2024-06-21
Some 1,000 years ago, a small band of Polynesians sailed thousands of miles across the Pacific to settle one of the world’s most isolated places—a small, previously uninhabited island they named Rapa Nui. There, they erected hundreds of “moai,” or gigantic stone statues that now famously stand as emblems of a vanished civilization. Eventually, their numbers ballooned to unsustainable levels; they chopped down all the trees, killed off the seabirds, exhausted the soils and in the end, ruined their environment. Their population and civilization collapsed, with just a few thousand people remaining when ...
Chilling discovery: Study reveals evolution of human cold and menthol sensing protein, offering hope for future non-addictive pain therapies.
2024-06-21
Chronic pain affects millions worldwide, and current treatments often rely on opioids, which carry risks of addiction and overdose.
Non-addictive alternatives could revolutionize pain management, and new research targeting the human protein which regulates cold sensations, brings scientists closer to developing pain medications that don't affect body temperature and don't carry the risks of addiction.
Research published in Science Advances on June 21, led by Wade Van Horn, professor in Arizona State University’s School of Molecular Sciences and Biodesign ...
Elena Beccalli, new rector of Università Cattolica del Sacro Cuore, takes office on 1st July
2024-06-21
Elena Beccalli will be rector of the Università Cattolica del Sacro Cuore on 1st July for the four-year term 2024–2028. After being appointed by the University's Board of Directors, which convened today, Thursday 20 June 2024, Professor Beccalli succeeds Professor Franco Anelli. She is the first woman appointed to this role in the history of our university.
The decision of the Board of Directors follows the appointment of Professor Elena Beccalli, Dean of the School of Banking, Finance, and Insurance ...
Pacific Northwest Research Institute uncovers hidden DNA mechanisms of rare genetic diseases
2024-06-21
Seattle, WA — June 21, 2024 — Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders. Their latest study, funded by the National Institutes of Health[1] and published in the journal Cell Genomics, reveals how specific DNA rearrangements called inverted triplications contribute to the development of various genetic diseases.
Understanding the Study
Genomic disorders occur when there are changes or mutations in DNA that disrupt normal biological functions. These can lead ...
Empowering older adults: Wearable tech made easier with personalized support
2024-06-21
(Toronto, June 20, 2024) A new review in the Journal of Medical Internet Research, published by JMIR Publications, found that community-dwelling older adults are more likely to continue using wearable monitoring devices (WMDs), like trackers, pedometers, and smartwatches, if they receive support from health care professionals or peers.
The research team from The Hong Kong Polytechnic University, led by Dr. Arkers Kwan Ching Wong, reviewed data from 3 randomized controlled trials involving over 150 older adults. The evaluation showed that the interventions that focused on increasing awareness of being monitored and used collaborative goal-setting and feedback tools, such as the SystemCHANGE ...
Pennington Biomedical researchers partner on award-winning Long Covid study
2024-06-21
Dr. John Kirwan, Executive Director of Pennington Biomedical Research Center, is serving as a co-principal investigator on the Pathobiology in RECOVER of Metabolic and Immune Systems, or PROMIS, study. The study has been awarded more than $802,000 by the National Institutes of Health to identify potential causes of Long COVID.
“The PROMIS study will help us better understand what is driving Long COVID,” Dr. Kirwan said. “In the early days of the pandemic, Pennington Biomedical directed its resources to address the urgent health needs of our population. Now with estimates that more than 25 percent of people in the U.S. who had COVID have experienced ...
Cooling ‘blood oranges’ could make them even healthier – a bonus for consumers
2024-06-21
An orange teeming with antioxidants and other health benefits may be a shot in the arm for consumers and citrus growers, if the fruit is stored at cool temperatures, a new University of Florida study shows.
But it’s too soon to know if the so-called “blood oranges” are a viable crop for the Florida citrus industry, says Ali Sarkhosh, a UF/IFAS associate professor of horticultural sciences. Sarkhosh’s post-doctoral associate Fariborz Habibi explains further.
“Although blood oranges typically command higher prices than other common varieties, such as navel or ...
Body image and overall health found important to the sexual health of older gay men, according to new studies
2024-06-21
According to a National Poll on Healthy Aging, 93% of people in the U.S. between 50-80 years old report experiencing at least one form of ageism from other people. Internalized ageism is when a person believes ageist ideas about themselves, such as thinking they had a “senior moment” or thinking they are too old to learn new technology. Internalizing ageist stereotypes can impact older people’s mental and physical health, including sexual health. Various aspects of older adults’ sexual ...
Lab-grown muscles reveal mysteries of rare muscle diseases
2024-06-21
DURHAM, N.C. – Biomedical engineers at Duke University have developed a new technique to better understand and test treatments for a group of extremely rare muscle disorders called dysferlinopathy or limb girdle muscular dystrophies 2B (LGMD2B). The approach grows complex, functional 3D muscle tissue from stem cells in the laboratory, creating a platform that replicates patient symptoms and treatment responses.
In its debut study, researchers reveal some of the biological mechanisms underlying the characteristic loss of mobility caused by LGMD2B. They also demonstrate that a combination of existing treatments may be able to alleviate some ...
Primary hepatic angiosarcoma: Treatment options for a rare tumor
2024-06-21
“[...] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach to achieve the best patient outcomes.”
BUFFALO, NY- June 21, 2024 – A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Primary hepatic angiosarcoma: Treatment options for a rare tumor.”
In this new editorial, researchers Gregory L. Guzik and Ankit Mangla from University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer ...